BSE: GENESIS · Healthcare · Biotechnology · Market cap ₹406 Cr
· Prev close ₹85.36 · Volume 2
Company profile: not in our data yet
Return on capital: not in our data yet
Median of the other 6: 10.1%
Profit, last 4 quarters vs the 4 before: not in our data yet
Generated In FY26 net profit was −120.4% on FY25.
P/E not shown: the EPS for the 4 quarters Sep 2025 to Jun 2026 is a loss
Generated The other 4 listed peers have a median P/E of 26.3×.
Of profit came in as cash, last 5 fiscal years: not in our data yet
100%: all profit arrived as cash
Generated Operating cash was negative in FY25 and positive in the other one year; FY26 alone brought in ₹5 cr. Total debt was ₹0 cr at the end of FY26, against a net worth of ₹40 cr.
Held by domestic funds: not in our data yet
In 1 month: not in our data yet
Generated The close is below its 20-day average of ₹92.
An earnings call transcript: not in our data yet
Scored statements from the earnings calls: none yet.
Earnings outlook Generated
In Q1 FY27 (Jun 26), net profit was −123.7% on the year-earlier quarter.
An earnings call transcript: not in our data yet